Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		Phase I/II trial of ZD1839 (Iressa) in pediatric patients newly diagnosed with brain stem tumors or incompletely resected supratentorial malignant gliomas.

		Keywords:		Iressa

		Phase:		Phase 1/2

		Treatment ID#s:		VT1271

		Age Group:		Pediatric Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Newly Diagnosed: Y Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed Phase II limited to Brain stem tumors

		Last Updated:		11/13/2005

		Tumor Types:		Anaplastic Astrocytoma Brainstem Glioma Craniopharyngioma Ganglioglioma Glioblastoma Multiforme Gliosarcoma Medulloblastoma Oligodendroglioma High Grade Pediatric Brain Tumors PNET Tumor Recurrent Malignant Pediatric Brain Tumors


		Comments:		See http://www.cancer.duke.edu/btc/ for details!

		Treatment Type:		Less-Toxics Immunological, Biological or Targeted Therapy.

		Contact:		The Brain Tumor Center at Duke Henry Friedman, MD Contact: Dr. Henry S. Friedman Rm 047 Baker House, Hospital South Trent Drive Durham, NC 27710- Phone:(919)684-5301 Fax: (919)684-6674 Click here to send an email Website: www.cancer.duke.edu/btc

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By